MétaCan
Menu
Back to cohort
Record W4399929256 · doi:10.1111/all.16178

Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort

2024· article· en· W4399929256 on OpenAlexaff
Eve Denton, Mark Hew, Matthew Peters, John W. Upham, Lakmini Bulathsinhala, Trung N. Tran, Neil Martin, Céline Bergeron, Mona Al‐Ahmad, Alan Altraja, Désirée Larenas‐Linnemann, Ruth Murray, C.A. Celis-Preciado, Riyad Al‐Lehebi, Manon Belhassen, Mohit Bhutani, Sinthia Bosnic‐Anticevich, Arnaud Bourdin, Guy Brusselle, John Busby, Giorgio Walter Canonica, Enrico Heffler, Kenneth R. Chapman, Jérémy Charriot, George Christoff, Li Ping Chung, Borja G. Cosío, Andréanne Côté, Richard W. Costello, Breda Cushen, James Fingleton, João Fonseca, Peter G. Gibson, Liam G. Heaney, Wan‐Chun Huang, Takashi Iwanaga, David J. Jackson, Mariko Siyue Koh, Lauri Lehtimäki, Jorge Máspero, Bassam Mahboub, Andrew Menzies‐Gow, Patrick Mitchell, Nikolaos G. Papadopoulos, Andriana Ι. Papaioannou, Luis Pérez de Llano, Diahn‐Warng Perng, Paul Pfeffer, Todor A. Popov, Celeste Porsbjerg, Chin Kook Rhee, Nicolás Roche, Mohsen Sadatsafavi, Sundeep Salvi, Johannes Martin Schmid, Chau‐Chyun Sheu, Concetta Sirena, Carlos A. Torres‐Duque, Laila Salameh, Pujan H. Patel, Charlotte Suppli Ulrik, Eileen Wang, Michael E. Wechsler, David Price

Bibliographic record

VenueAllergy · 2024
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsUniversité LavalUniversity of TorontoUniversity of AlbertaVancouver General HospitalUniversity of British Columbia
FundersOptimum Patient CareSanofiGlaxoSmithKlineTeva Pharmaceutical IndustriesSeqirusAstraZeneca
KeywordsMedicineAsthmaCohortCohort studyInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background Biologic asthma therapies reduce exacerbations and long‐term oral corticosteroids (LTOCS) use in randomized controlled trials (RCTs); however, there are limited data on outcomes among patients ineligible for RCTs. Hence, we investigated responsiveness to biologics in a real‐world population of adults with severe asthma. Methods Adults in the International Severe Asthma Registry (ISAR) with ≥24 weeks of follow‐up were grouped into those who did, or did not, initiate biologics (anti‐IgE, anti‐IL5/IL5R, anti‐IL4/13). Treatment responses were examined across four domains: forced expiratory volume in 1 second (FEV 1 ) increase by ≥100 mL, improved asthma control, annualized exacerbation rate (AER) reduction ≥50%, and any LTOCS dose reduction. Super‐response criteria were: FEV 1 increase by ≥500 mL, new well‐controlled asthma, no exacerbations, and LTOCS cessation or tapering to ≤5 mg/day. Results 5.3% of ISAR patients met basic RCT inclusion criteria; 2116/8451 started biologics. Biologic initiators had worse baseline impairment than non‐initiators, despite having similar biomarker levels. Half or more of initiators had treatment responses: 59% AER reduction, 54% FEV 1 increase, 49% improved control, 49% reduced LTOCS, of which 32%, 19%, 30%, and 39%, respectively, were super‐responses. Responses/super‐responses were more frequent in biologic initiators than in non‐initiators; nevertheless, ~40–50% of initiators did not meet response criteria. Conclusions Most patients with severe asthma are ineligible for RCTs of biologic therapies. Biologics are initiated in patients who have worse baseline impairments than non‐initiators despite similar biomarker levels. Although biologic initiators exhibited clinical responses and super‐responses in all outcome domains, 40–50% did not meet the response criteria.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.180
Threshold uncertainty score0.295

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.287
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAllergySame topicAsthma and respiratory diseasesFrench-language works237,207